Search Results - "Ivantsov, Alexandr O."

Gastric Cancer in BRCA1 Germline Mutation Carriers: Results of Endoscopic Screening and Molecular Analysis of Tumor Tissues.

Authors: Avanesyan, Albina A. Sokolenko, Anna P. Ivantsov, Alexandr O. et al.

Source: Pathobiology. 2020, Vol. 87 Issue 6, p367-374. 8p.

First-Line Cetuximab Monotherapy in KRAS/NRAS/BRAF Mutation-Negative Colorectal Cancer Patients.

Authors: Moiseyenko, Vladimir M. Moiseyenko, Fedor V. Yanus, Grigoriy A. et al.

Source: Clinical Drug Investigation. Jun2018, Vol. 38 Issue 6, p553-562.

Cost-Efficient Detection of NTRK1/2/3 Gene Fusions: Single-Center Analysis of 8075 Tumor Samples.

Authors: Romanko, Aleksandr A. Mulkidjan, Rimma S. Tiurin, Vladislav I. et al.

Source: International Journal of Molecular Sciences. Sep2023, Vol. 24 Issue 18, p14203. 12p.

Rapid and Cost-Efficient Detection of RET Rearrangements in a Large Consecutive Series of Lung Carcinomas.

Authors: Tiurin, Vladislav I. Preobrazhenskaya, Elena V. Mitiushkina, Natalia V. et al.

Source: International Journal of Molecular Sciences. Jul2023, Vol. 24 Issue 13, p10530. 10p.

Discrimination between Complete versus Non-Complete Pathologic Response to Neoadjuvant Therapy Using Ultrasensitive Mutation Analysis: A Proof-of-Concept Study in BRCA1 -Driven Breast Cancer Patients.

Authors: Sokolenko, Anna P. Moiseyenko, Fedor V. Iyevleva, Aglaya G. et al.

Source: International Journal of Molecular Sciences. Feb2023, Vol. 24 Issue 3, p1870. 10p.

Comprehensive evaluation of the test for 5′‐/3′‐end mRNA unbalanced expression as a screening tool for ALK and ROS1 fusions in lung cancer.

Authors: Mitiushkina, Natalia V. Romanko, Alexandr A. Preobrazhenskaya, Elena V. et al.

Source: Cancer Medicine. Sep2022, Vol. 11 Issue 17, p3226-3237. 12p.

Preparation of Duplex Sequencing Libraries for Archival Paraffin-Embedded Tissue Samples Using Single-Strand-Specific Nuclease P1.

Authors: Mitiushkina, Natalia V. Yanus, Grigory A. Kuligina, Ekatherina Sh. et al.

Source: International Journal of Molecular Sciences. May2022, Vol. 23 Issue 9, p4586-4586. 14p.

Neoadjuvant therapy of BRCA1-driven ovarian cancer by combination of cisplatin, mitomycin C and doxorubicin.

Authors: Gorodnova, Tatiana V. Sokolenko, Anna P. Kotiv, Khristina B. et al.

Source: Hereditary Cancer in Clinical Practice. 2/3/2021, Vol. 19 Issue 1, p1-7. 7p.

Revisiting multiple erroneous genetic testing results and clinical misinterpretations in a patient with Li-Fraumeni syndrome: lessons for translational medicine.

Authors: Sokolova, Tatiana N. Breder, Valeriy V. Shumskaya, Irina S. et al.

Source: Hereditary Cancer in Clinical Practice. 1/6/2021, Vol. 19 Issue 1, p1-7. 7p.

Rapid selection of BRCA1-proficient tumor cells during neoadjuvant therapy for ovarian cancer in BRCA1 mutation carriers.

Authors: Sokolenko, Anna P. Savonevich, Elena L. Ivantsov, Alexandr O. et al.

Source: Cancer Letters. Jul2017, Vol. 397, p127-132. 6p.

High response rates to neoadjuvant platinum-based therapy in ovarian cancer patients carrying germ-line BRCA mutation.

Authors: Gorodnova, Tatiana V. Sokolenko, Anna P. Ivantsov, Alexandr O. et al.

Source: Cancer Letters. Dec2015, Vol. 369 Issue 2, p363-367. 5p.

EGFR T790M Mutation in TKI-Naïve Clinical Samples: Frequency, Tissue Mosaicism, Predictive Value and Awareness on Artifacts.

Authors: Lavdovskaia, Elena D. Iyevleva, aglaya G. Sokolenko, anna P. et al.

Source: Oncology Research & Treatment. Oct2018, Vol. 41 Issue 10, p634-642. 9p.

Survival Outcomes in EGFR Mutation-Positive Lung Cancer Patients Treated with Gefitinib until or beyond Progression.

Authors: Moiseyenko, Fedor V. Moiseyenko, Vladimir M. Aleksakhina, Svetlana N. et al.

Source: Oncology Research & Treatment. Oct2016, Vol. 39 Issue 10, p605-614. 8p.

Molecular predictors of the outcome of paclitaxel plus carboplatin neoadjuvant therapy in high-grade serous ovarian cancer patients.

Authors: Sokolenko, Anna P. Gorodnova, Tatiana V. Bizin, Ilya V. et al.

Source: Cancer Chemotherapy & Pharmacology. Sep2021, Vol. 88 Issue 3, p439-450. 12p.

Comparative analysis of expression of mutant and wild-type alleles is essential for reliable PCR-based detection of MET exon 14 skipping.

Authors: Mitiushkina, Natalia V. Kholmatov, Maxim M. Tiurin, Vladislav I. et al.

Source: Biochimie. Oct2019, Vol. 165, p267-274. 8p.

Novel ALK fusion partners in lung cancer.

Authors: Iyevleva, Aglaya G. Raskin, Grigory A. Tiurin, Vladislav I. et al.

Source: Cancer Letters. Jun2015, Vol. 362 Issue 1, p116-121. 6p.

Coding polymorphisms in Casp5, Casp8 and DR4 genes may play a role in predisposition to lung cancer

Authors: Ulybina, Yulia M. Kuligina, Ekatherina Sh. Mitiushkina, Nathalia V. et al.

Source: Cancer Letters. Jun2009, Vol. 278 Issue 2, p183-191. 9p.

The spectrum of Lynch syndrome-associated germ-line mutations in Russia.

Authors: Yanus, Grigoriy A. Akhapkina, Tatiana A. Iyevleva, Aglaya G. et al.

Source: European Journal of Medical Genetics. Mar2020, Vol. 63 Issue 3, pN.PAG-N.PAG. 1p.

HLA gene polymorphism is a modifier of age-related breast cancer penetrance in carriers of BRCA1 pathogenic alleles.

Authors: Kuligina ES Romanko AA Jankevic T et al.

Source: Breast cancer research and treatment [Breast Cancer Res Treat] 2025 Jan; Vol. 209 (2), pp. 341-354. Date of Electronic Publication: 2024 Sep 21.

Publication Type: Journal Article

Journal Info: Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE

Somatic loss of the remaining allele occurs approximately in half of CHEK2-driven breast cancers and is accompanied by a border-line increase of chromosomal instability.

Authors: Iyevleva AG Aleksakhina SN Sokolenko AP et al.

Source: Breast cancer research and treatment [Breast Cancer Res Treat] 2022 Apr; Vol. 192 (2), pp. 283-291. Date of Electronic Publication: 2022 Jan 12.

Publication Type: Journal Article

Journal Info: Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE